Wired Magazine Eric Niller Rafael de la Barrera reaches into a freezer and pulls out a plastic jug of rusty-red liquid. He wipes frost off the label: “Zika Virus – […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2019/12/CVVR-square-350px.png351351Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2016-06-22 11:00:002019-12-30 07:49:58Inside the U.S. Army Lab Racing to Create a Zika Vaccine
BOSTON – With $42 million in funding from the National Institutes of Health, scientists from Beth Israel Deaconess Medical Center (BIDMC) and Oregon Health & Science University (OHSU) will lead a five-year research initiative to advance efforts to cure and prevent HIV/AIDS. Dan Barouch, MD, PhD, Director of the Center for Virology and Vaccine Research at BIDMC, and Louis Picker, MD, Assistant Director of the OHSU Vaccine and Gene Therapy Institute, will lead a consortium of researchers from across the country exploring the mechanisms behind promising new HIV vaccine candidates and potential cure strategies.
https://cvvr.hms.harvard.edu/wp-content/uploads/2019/12/CVVR-square-350px.png351351Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2016-06-20 14:00:002019-12-30 07:50:25Top HIV Scientists Awarded $42 Million in National Institutes of Health Funding to Improve Efficacy of HIV Vaccine Platforms
BOSTON – New research in monkeys exposed to SIV, the animal equivalent of HIV, reveals what happens in the very earliest stages of infection, before virus is even detectable in the blood, which is a critical but difficult period to study in humans. The findings, published online today in the journal Cell, have important implications for vaccine development and other strategies to prevent infection.
https://cvvr.hms.harvard.edu/wp-content/uploads/2019/12/CVVR-square-350px.png351351Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2016-04-13 18:28:002019-12-30 07:51:05Researchers Uncover Earliest Events Following HIV Infection, Before Virus Is Detectable
The Center for Virology and Vaccine Research launched a Volunteer Registry for adults interested in clinical trial participation on December 21st, 2015. The new CVVR Clinical Trials Unit established the […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2019/12/CVVR-square-350px.png351351Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2016-01-15 16:51:222019-12-30 07:51:47CVVR Volunteer Registry is Now Live!
amfAR, The Foundation for AIDS Research, announced on July 21st that a CVVR research team has been awarded $2 million to pursue a range of strategies aimed at curing HIV. […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2019/12/CVVR-square-350px.png351351Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2015-07-30 14:49:322019-12-30 07:52:17amfAR Gives $2 Million to CVVR Researchers to Study HIV Eradication
Keith Reeves and colleagues at CVVR published in Nature Immunology this month that robust, durable, antigen-specific natural killer (NK) cell memory can be induced in primates after both infection and vaccination. This data […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2019/12/CVVR-square-350px.png351351Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2015-07-24 16:37:212019-12-30 07:53:12Does NK Memory Exist? The Reeves Lab Shows It Does
CVVR in the News: “Vaccine-Induced CD4 T Cells Lead to Adverse Effect in a Mouse Model of Infection” – Science Daily, Jan 15, 2015 “A study led by investigators at Beth Israel […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2019/12/CVVR-square-350px.png351351Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2015-07-24 14:39:282019-12-30 07:53:32The Bad Side of CD4 T Cells
Dan Barouch and colleagues reported in the journal Science on July 17th that an adenovirus-based HIV vaccine demonstrated complete protection in 50% of vaccinated animals against a series of repeated, heterologous, intrarectal […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2019/12/CVVR-square-350px.png351351Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2015-07-21 22:34:102019-12-30 07:54:13New Vaccine Shows Protection in Monkeys
Inside the U.S. Army Lab Racing to Create a Zika Vaccine
/in NewsWired Magazine Eric Niller Rafael de la Barrera reaches into a freezer and pulls out a plastic jug of rusty-red liquid. He wipes frost off the label: “Zika Virus – […]
Top HIV Scientists Awarded $42 Million in National Institutes of Health Funding to Improve Efficacy of HIV Vaccine Platforms
/in NewsBIDMC, OHSU to Lead Consortium Exploring Vaccine Candidate and Cure Strategies
BOSTON – With $42 million in funding from the National Institutes of Health, scientists from Beth Israel Deaconess Medical Center (BIDMC) and Oregon Health & Science University (OHSU) will lead a five-year research initiative to advance efforts to cure and prevent HIV/AIDS. Dan Barouch, MD, PhD, Director of the Center for Virology and Vaccine Research at BIDMC, and Louis Picker, MD, Assistant Director of the OHSU Vaccine and Gene Therapy Institute, will lead a consortium of researchers from across the country exploring the mechanisms behind promising new HIV vaccine candidates and potential cure strategies.
Researchers Uncover Earliest Events Following HIV Infection, Before Virus Is Detectable
/in NewsFindings Could Lead to New HIV Prevention Strategies
BOSTON – New research in monkeys exposed to SIV, the animal equivalent of HIV, reveals what happens in the very earliest stages of infection, before virus is even detectable in the blood, which is a critical but difficult period to study in humans. The findings, published online today in the journal Cell, have important implications for vaccine development and other strategies to prevent infection.
CVVR Volunteer Registry is Now Live!
/in NewsThe Center for Virology and Vaccine Research launched a Volunteer Registry for adults interested in clinical trial participation on December 21st, 2015. The new CVVR Clinical Trials Unit established the […]
amfAR Gives $2 Million to CVVR Researchers to Study HIV Eradication
/in NewsamfAR, The Foundation for AIDS Research, announced on July 21st that a CVVR research team has been awarded $2 million to pursue a range of strategies aimed at curing HIV. […]
Does NK Memory Exist? The Reeves Lab Shows It Does
/in NewsKeith Reeves and colleagues at CVVR published in Nature Immunology this month that robust, durable, antigen-specific natural killer (NK) cell memory can be induced in primates after both infection and vaccination. This data […]
The Bad Side of CD4 T Cells
/in NewsCVVR in the News: “Vaccine-Induced CD4 T Cells Lead to Adverse Effect in a Mouse Model of Infection” – Science Daily, Jan 15, 2015 “A study led by investigators at Beth Israel […]
New Vaccine Shows Protection in Monkeys
/in NewsDan Barouch and colleagues reported in the journal Science on July 17th that an adenovirus-based HIV vaccine demonstrated complete protection in 50% of vaccinated animals against a series of repeated, heterologous, intrarectal […]